Brand name · Ophthalmic / Ang-2 & VEGF
Vabysmo (Faricimab) J-Code / HCPCS Code
In short
Vabysmo is billed under HCPCS J2777 — Injection, faricimab-svoa, 0.1 mg. One billing unit is 0.1 mg.
Reference
- Code
- J2777 — Injection, faricimab-svoa, 0.1 mgMed-Code curated
- Billing unit
- 0.1 mg
- Same code in the directory
- Faricimab
- Labelers
- Genentech, Inc.
- J-code category
- Ophthalmic / Ang-2 & VEGF
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Vabysmofaricimab | Faricimab 6 mg/.05mL | Injection, SolutionIntravitreal | Genentech, Inc. | 50242-096 |
NDCs billed under J2777
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J2777 for Vabysmo. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Vabysmo | 50242-0096-01 | Genentech, Inc. | 0.05 | 60 |
| Vabysmo | 50242-0096-06 | Genentech, Inc. | 0.05 | 60 |